NBIX Neurocrine Biosciences, Inc.

Fundamentals / CIK 0000914475 / USD

Neurocrine Biosciences, Inc. reported $3.70B in revenue and net income of $702.5M for the trailing twelve months ended September 30, 2026 (up 41.2% year over year), with a 97.8% gross margin and a 24.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NBIX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$2.83B$1.42B$0-$376.4MFY 2016 Revenue: $15.00MFY 2016 Net Income: -$141.1M2016FY 2017 Revenue: $161.6MFY 2017 Net Income: -$142.5M2017FY 2018 Revenue: $451.2MFY 2018 Net Income: $21.10M2018FY 2019 Revenue: $788.1MFY 2019 Net Income: $37.00M2019FY 2020 Revenue: $1.05BFY 2020 Net Income: $407.3M2020FY 2021 Revenue: $1.13BFY 2021 Net Income: $89.60M2021FY 2022 Revenue: $1.49BFY 2022 Net Income: $154.5M2022FY 2023 Revenue: $1.89BFY 2023 Net Income: $249.7M2023FY 2024 Revenue: $2.36BFY 2024 Net Income: $341.3M2024FY 2025 Revenue: $2.86BFY 2025 Net Income: $478.6M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $2.86B $2.36B $1.89B $1.49B $1.13B $1.05B $788.1M $451.2M $161.6M $15.00M
Cost of Revenue $52.10M $34.00M $39.70M $23.20M $14.30M $10.10M -- $4.89M $1.25M $0
Gross Profit $2.81B $2.32B $1.85B $1.47B $1.12B $1.04B -- $446.3M $160.4M $15.00M
Research & Development $1.02B $731.1M $565.0M $463.8M $328.1M $275.0M -- $160.5M $121.8M $94.29M
Selling, General & Admin $1.16B $1.01B $887.6M $752.7M $583.3M $433.3M $354.1M $248.9M $169.9M $68.08M
Total Operating Expenses -- -- -- -- $1.03B $882.9M $715.8M $414.4M $293.0M $162.4M
Operating Income $619.1M $570.5M $250.9M $249.0M $102.5M $163.0M $72.30M $36.80M -$131.4M -$147.4M
EBITDA $649.2M $597.6M $272.2M $264.6M $113.4M $171.6M $79.70M $40.82M -$129.0M -$145.9M
Interest Income -- -- -- -- -- -- -- -- -- $2.84M
Interest Expense -- -- $4.60M $7.10M $25.80M $32.80M $32.00M $30.50M $19.52M $0
Income Before Tax $705.4M $486.0M $332.1M $213.9M $101.4M $106.7M $46.50M $21.80M -$142.5M -$141.1M
Income Tax Expense $226.8M $144.7M $82.40M $59.40M $11.80M -$300.6M $9.50M $700K $0 $0
Net Income $478.6M $341.3M $249.7M $154.5M $89.60M $407.3M $37.00M $21.10M -$142.5M -$141.1M
Basic EPS $4.81 $3.40 $2.56 $1.61 $0.95 $4.38 $0.40 $0.23 -$1.62 -$1.63
Diluted EPS $4.67 $3.29 $2.47 $1.56 $0.92 $4.16 $0.39 $0.22 -$1.62 -$1.63
Basic Shares Outstanding 99.5M 100.4M 97.7M 95.8M 94.6M 93.1M 91.6M 90.2M 88.1M 86.7M
Diluted Shares Outstanding 102.5M 103.7M 101.0M 98.9M 97.9M 97.8M 95.7M 95.4M 88.1M 86.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.12B $959.0M $814.5M $805.5M $794.9M $687.5M $572.6M $627.7M
Cost of Revenue $26.60M $23.20M $13.80M $17.60M $14.00M $11.30M $9.20M $9.30M
Gross Profit $1.10B $935.8M $800.7M $787.9M $780.9M $676.2M $563.4M $618.4M
Research & Development $351.8M $326.7M $296.2M $258.2M $250.0M $244.3M $263.2M $185.6M
Selling, General & Admin $366.3M $439.7M $318.5M $301.8M $291.6M $286.3M $276.5M $287.8M
Operating Income $331.3M $151.5M $193.4M $210.9M $239.0M $145.6M $23.60M $142.0M
EBITDA $375.3M $176.3M $200.7M $218.4M $246.7M $152.9M $31.20M $149.1M
Interest Expense $300K $2.90M -- -- $0 $0 -- --
Income Before Tax $283.7M $162.2M $246.8M $239.4M $291.8M $159.5M $14.70M $162.6M
Income Tax Expense $77.20M $17.80M $48.90M $85.70M $82.30M $52.00M $6.80M $59.50M
Net Income $206.5M $144.4M $197.9M $153.7M $209.5M $107.5M $7.90M $103.1M
Basic EPS $2.03 $1.43 $1.97 -- $2.11 $1.09 $0.08 --
Diluted EPS $1.96 $1.39 $1.91 -- $2.04 $1.06 $0.08 --
Basic Shares Outstanding 101.6M 101.0M 100.5M -- 99.4M 99.0M 99.7M --
Diluted Shares Outstanding 105.2M 104.2M 103.4M -- 102.5M 101.0M 102.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $713.0M $233.0M $251.1M $262.9M $340.8M $187.1M $112.3M $141.7M $254.7M $83.27M
Short-Term Investments $767.4M $843.1M $780.5M $726.4M $370.5M $613.9M $558.2M $509.2M $261.2M --
Cash & Short-Term Investments $1.48B $1.08B $1.03B $989.3M $711.3M $801.0M $670.5M $650.9M $515.9M $83.27M
Accounts Receivable, Net $686.8M $479.1M $439.3M $350.0M $185.5M $157.1M $126.6M $57.41M $31.13M $0
Inventory $69.00M $57.40M $38.30M $35.10M $30.50M $28.00M $17.30M $10.86M $1.02M $0
Other Current Assets $115.8M $63.60M $97.80M $79.10M $45.50M $30.10M $16.60M $18.59M $6.84M $3.09M
Total Current Assets $2.52B $1.72B $1.61B $1.45B $972.8M $1.02B $831.0M $737.8M $554.9M $310.4M
Property, Plant & Equipment, Net $89.80M $82.60M $70.80M $58.60M $58.60M $44.60M $41.90M $33.87M $10.81M $6.27M
Goodwill $6.10M $5.70M $5.80M $5.40M $0 -- -- -- -- --
Intangible Assets $4.70M $36.50M $35.50M $37.20M $0 -- -- -- -- --
Long-Term Investments $1.06B $739.5M $687.5M $299.4M $560.7M $227.1M $299.7M $216.0M $247.4M --
Other Non-Current Assets $48.70M $52.00M $49.60M $25.00M $4.40M $6.40M $0 -- -- --
Total Non-Current Assets $2.11B $1.99B $1.64B $915.2M $1.10B $718.5M $475.0M $255.4M $262.7M $54.64M
Total Assets $4.63B $3.72B $3.25B $2.37B $2.07B $1.73B $1.31B $993.2M $817.6M $365.1M
Accounts Payable -- -- -- -- -- -- -- $13.80M $5.65M $5.08M
Other Current Liabilities $69.10M $46.10M $35.90M $20.70M $20.00M $17.80M $15.20M $1.86M $906K $0
Total Current Liabilities $743.4M $507.7M $654.8M $537.7M $245.8M $186.5M $565.3M $88.23M $54.43M $30.41M
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- $10.23M $10.23M $10.23M
Other Non-Current Liabilities $219.7M $166.2M $106.3M $29.70M $12.30M $9.70M $17.10M $35.66M $0 $113K
Total Non-Current Liabilities $635.0M $621.3M $364.6M $123.2M $452.7M $422.0M $103.8M $424.2M $391.0M $19.80M
Total Liabilities $1.38B $1.13B $1.02B $660.9M $698.5M $608.5M $669.1M $512.4M $445.5M $50.21M
Total Debt (incl. Leases) $471.3M $495.7M $290.3M $110.9M $121.8M $104.7M $95.04M -- -- --
Common Stock $100K $100K $100K $100K $100K $100K $100K $91K $89K $87K
Retained Earnings $447.7M $29.20M -$157.1M -$406.8M -$635.8M -$725.4M -$1.13B -$1.18B -$1.20B -$1.06B
Accumulated Other Comp. Income $13.10M $5.80M $7.00M -$7.90M -$1.70M $1.80M $1.40M -$1.93M -$1.85M -$318K
Total Stockholders' Equity $3.25B $2.59B $2.23B $1.71B $1.37B $1.13B $636.9M $480.8M $372.2M $314.9M
Total Equity $3.25B $2.59B $2.23B $1.71B $1.37B $1.13B $636.9M $480.8M $372.2M $314.9M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $641.5M $332.4M $266.5M $713.0M $340.2M $264.0M $194.1M $233.0M
Short-Term Investments $96.40M $57.40M $1.05B $767.4M $774.6M $711.6M $749.4M $843.1M
Cash & Short-Term Investments $737.9M $389.8M $1.32B $1.48B $1.11B $975.6M $943.5M $1.08B
Accounts Receivable, Net $957.3M $887.0M $768.1M $686.8M $728.0M $595.7M $516.0M $479.1M
Inventory $66.10M $104.2M $64.50M $69.00M $69.30M $56.90M $59.10M $57.40M
Other Current Assets $34.50M $39.40M $62.50M $115.8M $68.20M $120.7M $119.3M $63.60M
Total Current Assets $2.01B $1.64B $2.44B $2.52B $2.16B $1.75B $1.64B $1.72B
Property, Plant & Equipment, Net $92.20M $90.50M $90.90M $89.80M $97.30M $91.70M $87.00M $82.60M
Goodwill $500.6M $500.6M $6.00M $6.10M -- -- -- $5.70M
Intangible Assets $2.19B $2.23B -- $4.70M $35.70M $37.20M $36.40M $36.50M
Long-Term Investments $51.80M $91.90M $1.33B $1.06B $998.5M $873.8M $815.3M $739.5M
Other Non-Current Assets $61.90M $59.30M $73.60M $48.70M $20.30M $21.60M $15.30M $52.00M
Total Non-Current Assets $3.62B $3.72B $2.47B $2.11B $2.11B $2.14B $2.05B $1.99B
Total Assets $5.63B $5.36B $4.91B $4.63B $4.27B $3.89B $3.69B $3.72B
Other Current Liabilities $61.20M $66.20M $58.70M $69.10M $53.70M $56.80M $47.70M $46.10M
Total Current Liabilities $984.6M $874.5M $831.7M $743.4M $638.0M $546.3M $522.9M $507.7M
Other Non-Current Liabilities $266.8M $297.7M $260.9M $219.7M $195.7M $210.1M $181.6M $166.2M
Total Non-Current Liabilities $764.1M $791.0M $667.1M $635.0M $624.1M $649.2M $629.1M $621.3M
Total Liabilities $1.75B $1.67B $1.50B $1.38B $1.26B $1.20B $1.15B $1.13B
Total Debt (incl. Leases) $451.8M $461.6M $463.5M $471.3M $479.7M $489.8M $493.1M $495.7M
Common Stock $100K $100K $100K $100K $100K $100K $100K $100K
Retained Earnings $838.4M $724.0M $589.6M $447.7M $294.0M $84.50M -$5.30M $29.20M
Accumulated Other Comp. Income $4.40M $5.10M $400K $13.10M $13.20M $12.50M $9.00M $5.80M
Total Stockholders' Equity $3.88B $3.69B $3.41B $3.25B $3.00B $2.69B $2.54B $2.59B
Total Equity $3.88B $3.69B $3.41B $3.25B $3.00B $2.69B $2.54B $2.59B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $478.6M $341.3M $249.7M $154.5M $89.60M $407.3M $37.00M $21.11M -$142.5M -$141.1M
Depreciation & Amortization $30.10M $27.10M $21.30M $15.60M $10.90M $8.60M $7.40M $4.02M $2.40M $1.45M
Stock-Based Compensation $217.9M $195.5M $194.3M $173.1M $134.2M $100.0M $75.30M $58.10M $42.52M $28.46M
Change in Receivables -$210.5M -$39.80M -$89.30M -$162.2M -$28.40M -$30.50M -$69.20M -$25.10M -$31.13M $0
Change in Inventory -$15.30M -$19.10M $5.40M -$2.60M -$2.50M -$10.70M -$6.40M -$3.50M -$1.02M $0
Operating Cash Flow $782.7M $595.4M $389.9M $339.4M $256.5M $228.5M $147.0M $101.4M -$94.33M -$106.2M
Capital Expenditure -$34.00M -$38.20M -$28.30M -$16.50M -$23.40M -$10.90M -$14.70M -$24.80M -$6.94M -$4.11M
Free Cash Flow $748.7M $557.2M $361.6M $322.9M $233.1M $217.6M $132.3M $76.60M -$101.3M -$110.3M
Acquisitions, Net -- $0 $0 -$42.70M $0 $0 -- -- -- --
Purchases of Investments -$1.32B -$1.06B -$1.38B -$621.2M -$800.1M -$735.5M -$797.2M -$546.0M -$583.4M -$298.8M
Investing Cash Flow -$264.4M -$126.8M -$467.1M -$177.1M -$130.2M $4.10M -$211.1M -$242.9M -$251.3M $113.0M
Common Stock Issued $129.4M $122.1M $65.30M $44.70M $27.50M $29.10M $32.40M $29.50M $13.87M $2.39M
Share Repurchases -$167.7M -$300.0M $0 $0 -- -- -- -- -- --
Financing Cash Flow -$38.30M -$486.7M $65.30M -$234.3M $27.40M -$157.8M $32.40M $29.50M $516.6M $2.39M
Net Change in Cash $480.0M -$18.10M -$11.60M -$73.30M $153.7M $74.80M -$31.70M -$112.0M $171.1M $9.16M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $206.5M $144.4M $197.9M $153.7M $209.5M $107.5M $7.90M $103.1M
Depreciation & Amortization $44.00M $24.80M $7.30M $7.50M $7.70M $7.30M $7.60M $7.10M
Stock-Based Compensation $54.30M $65.00M $57.20M $58.60M $53.70M $52.80M $52.80M $66.40M
Change in Receivables -$70.20M -$84.30M -$81.40M $38.40M -$132.3M -$79.70M -$36.90M $2.00M
Change in Inventory $3.30M -$6.50M $4.30M -$3.40M -$12.30M $2.10M -$1.70M -$11.60M
Operating Cash Flow $395.2M $136.4M $145.8M $388.4M $227.5M $102.0M $64.80M $242.5M
Capital Expenditure -$11.60M -$7.80M -$9.10M $2.40M -$13.20M -$12.50M -$10.70M -$7.30M
Free Cash Flow $383.6M $128.6M $136.7M $390.8M $214.3M $89.50M $54.10M $235.2M
Purchases of Investments -$4.50M -$37.40M -$819.5M -$323.0M -$408.5M -$315.1M -$273.2M -$311.8M
Investing Cash Flow -$11.10M -$135.4M -$506.2M -$52.90M -$196.7M -$29.00M $14.20M -$68.30M
Common Stock Issued $25.30M $84.80M $23.60M $37.30M $45.60M $14.40M $32.10M $10.00M
Share Repurchases -$92.10M -$12.00M -$54.00M $0 $0 -$17.70M -$150.0M -$300.0M
Financing Cash Flow -$75.00M $63.40M -$86.10M $37.30M $45.60M -$3.30M -$117.9M -$290.0M
Net Change in Cash $309.1M $64.40M -$446.5M $372.8M $76.20M $69.90M -$38.90M -$116.1M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 98.2% 98.6% 97.9% 98.4% 98.7% 99.0% -- 98.9% 99.2% 100.0%
Operating Margin 21.6% 24.2% 13.3% 16.7% 9.0% 15.6% 9.2% 8.2% -81.3% -982.5%
Net Profit Margin 16.7% 14.5% 13.2% 10.4% 7.9% 38.9% 4.7% 4.7% -88.2% -940.6%
Return on Equity (ROE) 14.7% 13.2% 11.2% 9.0% 6.5% 36.2% 5.8% 4.4% -38.3% -44.8%
Return on Assets (ROA) 10.3% 9.2% 7.7% 6.5% 4.3% 23.5% 2.8% 2.1% -17.4% -38.6%
Current Ratio 3.39x 3.40x 2.45x 2.70x 3.96x 5.45x 1.47x 8.36x 10.20x 10.21x
Quick Ratio 3.30x 3.28x 2.40x 2.64x 3.83x 5.30x 1.44x 8.24x 10.18x 10.21x
Debt to Equity 0.14x 0.19x 0.13x 0.06x 0.09x 0.09x 0.15x -- -- --
Revenue Growth (YoY) +21.4% +24.8% +26.8% +31.3% +8.4% +32.7% +74.7% +179.2% +977.5% -24.1%
Gross Profit Growth (YoY) +21.0% +25.7% +26.1% +30.9% +8.1% -- -- +178.3% +969.1% -24.1%
Operating Income Growth (YoY) +8.5% +127.4% +0.8% +142.9% -37.1% +125.4% +96.5% -- -- --
Net Income Growth (YoY) +40.2% +36.7% +61.6% +72.4% -78.0% +1000.8% +75.4% -- -- --
EPS Growth (YoY) +41.5% +32.8% +59.0% +69.5% -78.3% +995.0% +73.9% -- -- --
Operating Cash Flow Growth (YoY) +31.5% +52.7% +14.9% +32.3% +12.3% +55.4% +45.0% -- -- --
Free Cash Flow Growth (YoY) +34.4% +54.1% +12.0% +38.5% +7.1% +64.5% +72.7% -- -- --
5Y Revenue / Share Growth +155.9% +172.7% +286.1% +746.9% +6826.7% +4701.7% -- +11379.7% +126.6% -87.7%
10Y Revenue / Share Growth +12187.7% -- +44227.1% +1818.9% +754.0% +1671.3% +11302.8% -- -- --
5Y Net Income / Share Growth +9.9% +741.6% +992.6% -- -- -- -- -- -2213.1% -339.0%
10Y Net Income / Share Growth -- -- -- +2006.0% +39.1% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 97.8% 98.0% 98.2% 98.2% 98.4% 98.5% 98.5% 98.6%
Operating Margin 24.0% 23.6% 25.4% 21.6% 20.5% 19.7% 20.5% 24.2%
Net Profit Margin 19.0% 20.9% 21.6% 16.7% 16.0% 13.9% 12.7% 14.5%
Return on Equity (ROE) 18.1% 19.1% 19.6% 14.7% 14.2% 12.9% 12.1% 13.2%
Return on Assets (ROA) 12.5% 13.2% 13.6% 10.3% 10.0% 9.0% 8.3% 9.2%
Current Ratio 2.04x 1.87x 2.93x 3.39x 3.38x 3.20x 3.13x 3.40x
Quick Ratio 1.97x 1.75x 2.85x 3.30x 3.27x 3.10x 3.02x 3.28x
Debt to Equity 0.12x 0.12x 0.14x 0.14x 0.16x 0.18x 0.19x 0.19x
Revenue Growth (YoY) +41.2% +39.5% +42.2% +28.3% +27.8% +16.5% +11.1% +21.8%
Gross Profit Growth (YoY) +40.4% +38.4% +42.1% +27.4% +27.2% +16.4% +10.9% +22.0%
Operating Income Growth (YoY) +38.6% +4.1% +719.5% +48.5% +30.0% +0.1% -76.2% -5.5%
Net Income Growth (YoY) -1.4% +34.3% +2405.1% +49.1% +61.4% +65.4% -81.8% -30.2%
EPS Growth (YoY) -3.8% +31.2% +2362.5% -- +64.8% +70.3% -81.4% --
Operating Cash Flow Growth (YoY) +73.7% +33.7% +125.0% +60.2% +44.0% +57.9% -50.3% +96.4%
Free Cash Flow Growth (YoY) +79.0% +43.7% +152.7% +66.2% +43.0% +68.9% -54.6% +99.2%
Source: SEC EDGAR CompanyFacts (CIK 0000914475) · from December 31, 2009 Data through September 30, 2026 · synced Nov 20, 2026, 05:07 UTC · Open in terminal